Recent Finacing
Recent Raise
Anokion is a clinical-stage biotech developing antigen-specific immune-tolerance therapies via liver-targeted and erythrocyte-bound antigen platforms for autoimmune diseases including celiac disease and multiple sclerosis, based in Lausanne and Cambridge.
